This blog is related to the various litigations related to patents w.r.t pharma industry.
Wednesday, February 4, 2009
Abraxis BioScience Launches ABRAXANE in Germany
Feb 4, 2009 - Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced the launch in Germany of ABRAXANE, 5 mg/ml powder for suspension for infusion (paclitaxel).
No comments:
Post a Comment